Shanghai General Healthy Information and Technology Co. Ltd. (605186) - Net Assets
Based on the latest financial reports, Shanghai General Healthy Information and Technology Co. Ltd. (605186) has net assets worth CN¥1.19 Billion CNY (≈ $173.75 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.46 Billion ≈ $214.37 Million USD) and total liabilities (CN¥277.60 Million ≈ $40.62 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See Shanghai General Healthy Information and (605186) balance sheet quality index to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.19 Billion |
| % of Total Assets | 81.05% |
| Annual Growth Rate | 24.96% |
| 5-Year Change | 21.6% |
| 10-Year Change | N/A |
| Growth Volatility | 44.53 |
Shanghai General Healthy Information and Technology Co. Ltd. - Net Assets Trend (2016–2025)
This chart illustrates how Shanghai General Healthy Information and Technology Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see 605186 market cap overview.
Annual Net Assets for Shanghai General Healthy Information and Technology Co. Ltd. (2016–2025)
The table below shows the annual net assets of Shanghai General Healthy Information and Technology Co. Ltd. from 2016 to 2025. Also explore 605186 net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.19 Billion ≈ $173.58 Million |
+2.21% |
| 2024-12-31 | CN¥1.16 Billion ≈ $169.83 Million |
+2.01% |
| 2023-12-31 | CN¥1.14 Billion ≈ $166.48 Million |
+5.03% |
| 2022-12-31 | CN¥1.08 Billion ≈ $158.52 Million |
+11.04% |
| 2021-12-31 | CN¥975.54 Million ≈ $142.75 Million |
+11.16% |
| 2020-12-31 | CN¥877.62 Million ≈ $128.42 Million |
+149.95% |
| 2019-12-31 | CN¥351.11 Million ≈ $51.38 Million |
+37.39% |
| 2018-12-31 | CN¥255.56 Million ≈ $37.40 Million |
+43.22% |
| 2017-12-31 | CN¥178.44 Million ≈ $26.11 Million |
+11.75% |
| 2016-12-31 | CN¥159.68 Million ≈ $23.37 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shanghai General Healthy Information and Technology Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1444.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥568.63 Million | 51.56% |
| Other Components | CN¥534.31 Million | 48.44% |
| Total Equity | CN¥1.10 Billion | 100.00% |
Shanghai General Healthy Information and Technology Co. Ltd. Competitors by Market Cap
The table below lists competitors of Shanghai General Healthy Information and Technology Co. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kelly Services A Inc
NASDAQ:KELYA
|
$507.38 Million |
|
Guangbo Group Stock Co Ltd
SHE:002103
|
$507.39 Million |
|
Invesco Municipal Trust
NYSE:VKQ
|
$507.43 Million |
|
SGL Carbon SE
XETRA:SGL
|
$508.04 Million |
|
Shenzhen Soling Industrial Co Ltd
SHE:002766
|
$507.06 Million |
|
Kocaer Celik Sanayi ve Ticaret A.S.
IS:KCAER
|
$506.97 Million |
|
CapitaLand Malaysia Mall Trust
KLSE:5180
|
$506.92 Million |
|
Rolex Rings Limited
NSE:ROLEXRINGS
|
$506.81 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shanghai General Healthy Information and Technology Co. Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,071,647,096 to 1,102,934,329, a change of 31,287,233 (2.9%).
- Net income of 30,782,546 contributed positively to equity growth.
- Dividend payments of 3,987,597 reduced retained earnings.
- Other comprehensive income increased equity by 16,532,307.
- Other factors decreased equity by 12,040,023.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥30.78 Million | +2.79% |
| Dividends Paid | CN¥3.99 Million | -0.36% |
| Other Comprehensive Income | CN¥16.53 Million | +1.5% |
| Other Changes | CN¥-12.04 Million | -1.09% |
| Total Change | CN¥- | 2.92% |
Book Value vs Market Value Analysis
This analysis compares Shanghai General Healthy Information and Technology Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.14x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.47x to 3.14x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | CN¥53.84 | CN¥25.49 | x |
| 2017-12-31 | CN¥1.18 | CN¥25.49 | x |
| 2018-12-31 | CN¥1.91 | CN¥25.49 | x |
| 2019-12-31 | CN¥2.82 | CN¥25.49 | x |
| 2020-12-31 | CN¥7.98 | CN¥25.49 | x |
| 2021-12-31 | CN¥6.59 | CN¥25.49 | x |
| 2022-12-31 | CN¥7.38 | CN¥25.49 | x |
| 2023-12-31 | CN¥7.72 | CN¥25.49 | x |
| 2024-12-31 | CN¥7.91 | CN¥25.49 | x |
| 2025-12-31 | CN¥8.11 | CN¥25.49 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shanghai General Healthy Information and Technology Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.79%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.91%
- • Asset Turnover: 0.23x
- • Equity Multiplier: 1.36x
- Recent ROE (2.79%) is below the historical average (17.87%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 14.99% | 8.58% | 0.80x | 2.19x | CN¥5.86 Million |
| 2017 | 45.75% | 23.77% | 0.88x | 2.18x | CN¥43.29 Million |
| 2018 | 38.13% | 29.10% | 0.72x | 1.82x | CN¥55.06 Million |
| 2019 | 31.95% | 30.61% | 0.62x | 1.68x | CN¥63.14 Million |
| 2020 | 11.77% | 33.38% | 0.29x | 1.23x | CN¥14.42 Million |
| 2021 | 13.05% | 24.02% | 0.43x | 1.25x | CN¥27.47 Million |
| 2022 | 11.51% | 35.89% | 0.27x | 1.19x | CN¥15.18 Million |
| 2023 | 5.70% | 19.51% | 0.23x | 1.25x | CN¥-45.27 Million |
| 2024 | 3.03% | 10.22% | 0.22x | 1.37x | CN¥-74.64 Million |
| 2025 | 2.79% | 8.91% | 0.23x | 1.36x | CN¥-79.51 Million |
Industry Comparison
This section compares Shanghai General Healthy Information and Technology Co. Ltd.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $3,621,354,854
- Average return on equity (ROE) among peers: 117.41%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shanghai General Healthy Information and Technology Co. Ltd. (605186) | CN¥1.19 Billion | 14.99% | 0.23x | $507.28 Million |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $3.98 Billion | -16.09% | 0.31x | $422.24 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $13.36 Billion | 11.10% | 0.20x | $3.84 Billion |
| Double Medical Technology Inc (002901) | $3.16 Billion | 1.87% | 0.47x | $2.35 Billion |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $21.45K | 1180.66% | 90.26x | $520.92 Million |
| Lepu Medical Tech Beijing (300003) | $7.03 Billion | 12.79% | 0.82x | $3.09 Billion |
| INKON Life Technology Co Ltd (300143) | $1.32 Billion | -45.24% | 0.54x | $797.29 Million |
| Edan Instruments Inc (300206) | $1.85 Billion | 12.58% | 0.21x | $968.68 Million |
| Guangdong Biolight Meditech Co Ltd (300246) | $377.93 Million | 9.66% | 0.15x | $609.04 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.67 Billion | -1.38% | 0.06x | $460.12 Million |
| Sinocare Inc (300298) | $3.47 Billion | 8.19% | 0.71x | $1.28 Billion |
About Shanghai General Healthy Information and Technology Co. Ltd.
Shanghai General Healthy Information and Technology Co., Ltd. provides pharmaceutical logistics automation, information technology, and intelligent and mobile medical solutions in China. It operates through four segments: Smart Pharmacy Project, Intelligent Static Compounding Center Project, Intelligent Drug and Consumable Management Project, and Logistics and Mobile Robot Project. The company's … Read more